Literature DB >> 33693013

CircHIPK3: Key Player in Pathophysiology and Potential Diagnostic and Therapeutic Tool.

Jiang Zhou1, Baisheng Wang1, Xin Bin1, Changqing Xie1, Bo Li1, Ousheng Liu1, Zhangui Tang1.   

Abstract

A large number of studies in China and other countries have confirmed that circularHIPK3 (circHIPK3) plays an important role in the pathophysiological processes of various diseases. Through the action of sponge miRNA (miR), circHIPK3 regulates cell proliferation, differentiation, and migration, and plays a key role in disease processes. By referring to a large number of research reports, this article explores the specific functional role of circHIPK3 in fibrotic diseases, cancer, and other diseases. This review aims to clarify the role of circHIPK3 in disease processes in order to aid further studies into the specific pathogenesis and clinical diagnosis of various diseases and provide new ideas for treatments.
Copyright © 2021 Zhou, Wang, Bin, Xie, Li, Liu and Tang.

Entities:  

Keywords:  CircHIPK3; cancer; fibrosis; miRNA; pathophysiological; treatment

Year:  2021        PMID: 33693013      PMCID: PMC7937734          DOI: 10.3389/fmed.2021.615417

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  3 in total

1.  Endothelial cell-derived exosomal circHIPK3 promotes the proliferation of vascular smooth muscle cells induced by high glucose via the miR-106a-5p/Foxo1/Vcam1 pathway.

Authors:  Shaohua Wang; Min Shi; Jiao Li; Yuanyuan Zhang; Wenjing Wang; Peixin Xu; Yongjun Li
Journal:  Aging (Albany NY)       Date:  2021-12-10       Impact factor: 5.682

Review 2.  Potential Clinical Applications of Exosomal Circular RNAs: More than Diagnosis.

Authors:  Kearabetsoe Matseliso Molibeli; Rong Hu; Yuze Liu; Dehui Xiong; Lijun Tang
Journal:  Front Mol Biosci       Date:  2021-11-24

3.  Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma.

Authors:  Madonna R Peter; Fang Zhao; Renu Jeyapala; Shivani Kamdar; Wei Xu; Cynthia Hawkins; Andrew J Evans; Neil E Fleshner; Antonio Finelli; Bharati Bapat
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.